Showing 15 posts of 33 posts found.


Almost half of all cancer drug trials show bias and exaggeration

September 19, 2019
Research and Development BMJ, Cancer, cancer drug trials

New research on clinical trials between 2014 and 2016 raise “serious concerns about low standards” as over the three year …


Investigation questions Xarelto trial data accuracy

February 4, 2016
Medical Communications BMJ, Bayer, INR, Johnson & Johnson, New England Journal of Medicine, Rocket-AF, Xarelto, blood clotting, rivaroxaban

The ROCKET-AF trial, the pivotal trial of the top-selling anti-clotting drug Xarelto, could have been undermined by unreliable results from …

clinical trials

Governments and industry ‘combining to stall drug development’

November 9, 2015
Research and Development, Sales and Marketing BMJ, R&D, drug development

Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …

UK doctors urged to curb overtreatment

May 13, 2015
Sales and Marketing Academy of Medical Royal Colleges, BMJ, NHS, uk doctors

The UK’s body of medical colleges has launched a new campaign to warn of the dangers of over-treating patients with …


Apple research apps to require ethics board approval

April 30, 2015
Sales and Marketing Apple, BMJ, FDA, GP, researchkit

New guidelines will require apps developed for Apple’s ResearchKit health platform to be approved by an independent ethics board. The …

NHS image

NHS ‘close to breaking point’

April 30, 2015
Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund

England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …

Tamiflu image

Government spending on Tamfilu is justified

January 30, 2015
Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency

The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …

EMA image

Mixed response to EMA data transparency plans

October 3, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency

The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …

Should patients be able to email their general practitioner?

September 3, 2014
Medical Communications, Sales and Marketing BMJ, GPs, clinicians, econsultations, email

Email consultations with your doctor make better use of their time and are more convenient, or threaten safety and create …


Pradaxa ‘safe’ says Australian regulator

August 6, 2014
Research and Development, Sales and Marketing AF, Australia, BMJ, Pradaxa, stroke

Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …

Pradaxa image

BMJ investigation raises new concerns over Pradaxa

July 24, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, Boehringer, Channel 4, Pradaxa, blood, warfarin

An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …

Majority of consumed Viagra fake say researchers

July 3, 2014
Manufacturing and Production, Sales and Marketing BMJ, ED, Pfizer, Sildenafil, counterfeit, erectile dysfunction, viagra

At least two-thirds of Pfizer’s erectile dysfunction drug Viagra used in the Netherlands may be illegal, researchers are warning. In …

EMA building

BMJ slams EMA ‘U-turn’

May 30, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, EMA, alltrials, data, transparency

The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …

prescription image

Scrap ‘iniquitous and outdated’ NHS prescription charges

May 15, 2014
Sales and Marketing BMJ, NHS, charges, dab, drugs, prescription

The NHS prescription charge is iniquitous and outdated and needs to be scrapped, according to an editorial in the Drug …


Tamiflu stockpiling ‘unjustifiable’ and wasted £424m

April 10, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials

Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …

Latest content